Virpax Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
4.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.52
|
0.00
|
0.52
|
100.00%
|
|
2022-09-30
|
-0.45
|
-0.65
|
-0.20
|
-44.44%
|
|
2022-06-30
|
-0.44
|
-0.50
|
-0.06
|
-13.64%
|
|
2022-03-31
|
0.00
|
-0.44
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.34
|
-0.34
|
0.00
|
0.00%
|
|
2021-09-30
|
0.00
|
-0.53
|
0.00
|
0.00%
|
|
2021-06-30
|
0.00
|
-0.47
|
0.00
|
0.00%
|
|
2021-03-31
|
0.00
|
-0.60
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.59
|
|
2021-12-31
|
-1.94
|
|
2020-12-31
|
-2.51
|
|
2019-12-31
|
-1.07
|
|
2018-12-31
|
-0.27
|